KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 156 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q2 2015. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $20,998,000 | +15.7% | 278,825 | -22.9% | 0.03% | +20.0% |
| Q1 2015 | $18,146,000 | +21.6% | 361,825 | -15.9% | 0.02% | +19.0% |
| Q4 2014 | $14,917,000 | -38.5% | 430,125 | -41.9% | 0.02% | -38.2% |
| Q3 2014 | $24,256,000 | -15.2% | 740,412 | -0.6% | 0.03% | -19.0% |
| Q2 2014 | $28,594,000 | -23.9% | 745,212 | -21.2% | 0.04% | -26.3% |
| Q1 2014 | $37,578,000 | -11.8% | 945,120 | -17.4% | 0.06% | -17.4% |
| Q4 2013 | $42,623,000 | +119.8% | 1,144,229 | +169.7% | 0.07% | +86.5% |
| Q3 2013 | $19,391,000 | – | 424,318 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AlpInvest Partners B.V. | 33,271 | $1,277,000 | 4.55% |
| Palo Alto Investors LP | 949,959 | $36,450,000 | 2.71% |
| Redmile Group, LLC | 560,356 | $21,501,000 | 2.61% |
| SENZAR ASSET MANAGEMENT, LLC | 124,900 | $4,792,000 | 1.83% |
| Aureus Asset Management, LLC | 152,662 | $5,858,000 | 1.46% |
| PFM Health Sciences, LP | 952,715 | $36,556,000 | 0.73% |
| REGENTATLANTIC CAPITAL LLC | 176,454 | $6,771,000 | 0.63% |
| Polar Capital LLP | 519,398 | $19,927,000 | 0.42% |
| FNY Managed Accounts LLC | 2,500 | $95,925,000 | 0.35% |
| Partner Investment Management, L.P. | 36,173 | $1,388,000 | 0.28% |